Publications
Export 115 results:
Author Title [ Type
Filters: Author is Pedro Rosa-Neto [Clear All Filters]
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging.. Pharmaceuticals (Basel). 12(1)
.
2019. Publisher Correction: Microglial activation and tau propagate jointly across Braak stages.. Nat Med. 27(11):2048-2049.
.
2021. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.. JAMA Neurol.
.
2018. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease.. Transl Psychiatry. 11(1):251.
.
2021. Principal component of explained variance: An efficient and optimal data dimension reduction framework for association studies.. Stat Methods Med Res.
.
2016. The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database.. Alzheimers Dement (N Y). 3(1):107-113.
.
2017. Preliminary Evaluations of [C]Verubulin: Implications for Microtubule Imaging With PET.. Front Neurosci. 15:725873.
.
2021. Preclinical longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic.. J Cereb Blood Flow Metab. :271678X211035625.
.
2021. Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's disease.. Alzheimers Res Ther. 13(1):69.
.
2021. PET/CT of Dementia.. AJR Am J Roentgenol. 211(2):246-259.
.
2018. PET imaging with [¹⁸F]fluoroethoxybenzovesamicol ([¹⁸F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat.. Nucl Med Biol. 41(1):96-101.
.
2014. .
2018. Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's disease.. Neuroimage Clin. 31:102733.
.
2021. Odor identification as a biomarker of preclinical AD in older adults at risk.. Neurology. 89(4):327-335.
.
2017. Normal cognition in Parkinson's disease may involve hippocampal cholinergic compensation: An exploratory PET imaging study with [F]-FEOBV.. Parkinsonism Relat Disord. 91:162-166.
.
2021. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease.. Nat Commun. 10(1):4227.
.
2019. No apparent effect of naproxen on CSF markers of innate immune activation.. Ann Clin Transl Neurol. 6(6):1127-1133.
.
2019. Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.. Neurology. 88(19):1814-1821.
.
2017. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.. J Neurosci. 37(50):12263-12271.
.
2017. Morphometric network differences in ageing versus Alzheimer's disease dementia.. Brain. 143(2):635-649.
.
2020. Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain.. Alzheimers Res Ther. 9(1):25.
.
2017. Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views.. Curr Neurol Neurosci Rep. 21(10):52.
.
2021. Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease.. Mol Neurodegener. 16(1):28.
.
2021. MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research.. Trends Neurosci. 37(11):629-41.
.
2014. Microglial activation and tau propagate jointly across Braak stages.. Nat Med. 27(9):1592-1599.
.
2021.